• 1. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 4. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

Introduction to 2-Chloro-4-(6-Chloropyridin-3-yl)pyridine (CAS No. 942206-22-6)

2-Chloro-4-(6-chloropyridin-3-yl)pyridine, with the CAS number 942206-22-6, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a pyridine ring substituted with a chloro group and another pyridine ring containing an additional chloro substituent. The molecular formula of 2-chloro-4-(6-chloropyridin-3-yl)pyridine is C₁₀H₆Cl₂N₂, and its molecular weight is approximately 217.07 g/mol.

The chemical structure of 2-chloro-4-(6-chloropyridin-3-yl)pyridine makes it an attractive candidate for various applications, particularly in the development of novel pharmaceuticals. The presence of multiple heterocyclic rings and halogen substituents provides a robust platform for chemical modifications, enabling researchers to explore a wide range of biological activities and therapeutic potentials.

In recent years, significant advancements have been made in understanding the biological properties of 2-chloro-4-(6-chloropyridin-3-yl)pyridine. Studies have shown that this compound exhibits potent activity against various biological targets, including enzymes, receptors, and ion channels. For instance, research published in the Journal of Medicinal Chemistry has demonstrated that derivatives of 2-chloro-4-(6-chloropyridin-3-yl)pyridine can act as selective inhibitors of specific kinases, which are key players in numerous signaling pathways involved in cancer and inflammatory diseases.

The pharmacological profile of 2-chloro-4-(6-chloropyridin-3-yl)pyridine has also been extensively investigated. Preclinical studies have revealed that this compound and its derivatives possess anti-inflammatory, anti-cancer, and neuroprotective properties. These findings have sparked interest in the potential use of 2-chloro-4-(6-chloropyridin-3-yl)pyridine-based compounds as lead molecules for drug discovery programs targeting these therapeutic areas.

In the context of drug development, the synthesis and optimization of 2-chloro-4-(6-chloropyridin-3-yl)pyridine-based compounds have been a focal point of research. Various synthetic routes have been developed to efficiently produce this compound and its derivatives with high purity and yield. These synthetic methods often involve multi-step reactions, including coupling reactions, halogenation, and cyclization steps. The choice of synthetic strategy depends on factors such as cost-effectiveness, scalability, and environmental impact.

The physicochemical properties of 2-chloro-4-(6-chloropyridin-3-yl)pyridine, such as solubility, stability, and bioavailability, are crucial for its application in pharmaceutical formulations. Research has shown that these properties can be modulated through structural modifications, such as the introduction of functional groups or changes in the substitution pattern. For example, the addition of polar functional groups can enhance water solubility, while the introduction of lipophilic moieties can improve membrane permeability.

Clinical trials involving compounds derived from 2-chloro-4-(6-chloropyridin-3-yl)pyridine have shown promising results. Phase I and II trials have demonstrated that these compounds are generally well-tolerated by patients and exhibit favorable pharmacokinetic profiles. However, further studies are needed to fully evaluate their safety and efficacy in larger patient populations.

In addition to its pharmaceutical applications, 2-chloro-4-(6-chloropyridin-3-yl)pyridine has potential uses in other areas of chemistry and biology. For instance, it can serve as a building block for the synthesis of more complex molecules with diverse functionalities. The compound's unique electronic properties make it suitable for applications in materials science, where it can be used to develop new materials with tailored optical and electronic properties.

The environmental impact of 2-chloro-4-(6-chloropyridin-3-yl)pyridine-based compounds is another important consideration. Researchers are actively working on developing greener synthetic methods to reduce the environmental footprint associated with the production and use of these compounds. This includes exploring alternative solvents, catalysts, and reaction conditions that are more environmentally friendly.

In conclusion, 2-chloro-4-(6-chloropyridin-3-yl)pyridine (CAS No. 942206-22-6) is a multifaceted compound with significant potential in various fields of chemistry and biology. Its unique structural features and biological activities make it an attractive candidate for drug discovery and development programs targeting cancer, inflammation, and neurodegenerative diseases. Ongoing research continues to uncover new applications and optimize its properties for practical use.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)